RPID: Rapid Micro Biosystems Inc. Price to Sales

Symbol and logo of brand Rapid Micro (RPID)

Low equipment sales volumes are driving up unit costs, which supports the historical P/S level for Rapid Micro Biosystems (RPID). The value of 0.90 characterizes this valuation level. Technological superiority in rapid bacterial detection and cloud services mitigates these risks. Further stability is provided by a proprietary consumables model, which ensures significant pricing power in the automation of microbiological control.

RPID (Rapid Micro) P/S Multiple history from 07/04/2022 to 11/13/2026

Analytical breakdowns for Rapid Micro Biosystems (RPID)

- market price and analyst price targets:
Stock Quotes rapidmicrobio.com|RPID - Analyst Consensus Forecast
- market capitalization information:
Market Value Rapid Micro|RPID - Enterprise Value
- shareholders' equity book value data:
Equity per Share Rapid Micro Biosystems|RPID - Book Capitalization|Market Capitalization to Book Value rapidmicrobio.com|RPID - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Rapid Micro Biosystems|RPID - Long-Term Debt to Capital|Short-Term Debt to Capital rapidmicrobio.com|RPID - Company Debts|Debt to Book Capitalization Ratio Rapid Micro|RPID - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Rapid Micro Biosystems|Immediate Liquidity rapidmicrobio.com
- net income and valuation multiples indicators:
RPID - Company Net Income|Projected Net Profit Rapid Micro Biosystems|RPID - Price to Earnings Ratio|Forward P/E Multiple rapidmicrobio.com|RPID - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Rapid Micro|RPID - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Rapid Micro Biosystems|RPID - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months rapidmicrobio.com|RPID - Earnings growth in current year|Expected net earnings per share growth next year Rapid Micro Biosystems
- issuer revenue and sales details:
RPID - Company Revenue|Company Revenue Forecast rapidmicrobio.com|RPID - Market Cap to Revenue|Price to Expected Revenue Ratio Rapid Micro
Fundamental company analysis:Rapid Micro Biosystems Inc. RPID
Original product of Rapid Micro Biosystems

The P/S multiple determines the market value of a business relative to its annual sales volume, allowing for an assessment of the fundamental overpayment for an asset regardless of debt load. The current value of 0.90 in the price-to-sales multiple history reflects inflated expectations amid the slow adoption of analysis systems in the pharma sector and operating losses, which calls into question the sustainability of the current capitalization of Rapid Micro Biosystems (RPID).

Who Rapid Micro Biosystems competes with

Market Cap to Revenue abbott.com ABT|P/S Multiple TMO (Thermo Fisher)|GE HealthCare Technologies Inc. (GEHC) - Price to Sales|Mettler-Toledo International Inc. - P/S Multiple|WAT (Waters Technologies) - Market Cap to Revenue Ratio|TECH: P/S Multiple|BRKR - Price-to-Revenue Coefficient|AZTA (Azenta) - P/S Multiple|Market Cap to Revenue Varex Imaging Corp (VREX)|P/S Multiple SMLR|P/S Multiple Butterfly Corp (BFLY)|Price-to-Revenue Ratio Mesa Laboratories, Inc. MLAB|quantum-si.com - Price-to-Revenue Ratio|NNOX: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio QTRX (Quanterix Corp.)|MASS: P/S Multiple|Price to Sales CapsoVision (CV)|Price-to-Revenue Ratio MaxCyte, Inc.|SEER - Price-to-Revenue Multiple|Market Cap to Revenue HYPR (Hyperfine)|P/S Multiple FONAR Corp. (FONR)|P/S Multiple DXR (Daxor)|Price-to-Revenue Coefficient spectral-ai.com (MDAI)|VIVS - Price-to-Revenue Ratio|Price-to-Sales Ratio ACON|akoyabio.com (AKYA) - Price-to-Revenue Ratio|Market Cap to Revenue ThermoGenesis Holdings, Inc.|TLIS (Talis Biomedical Corp.) - P/S Multiple|Price to Sales T2 Biosystems Inc TTOO